Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04362072
Title Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements Yes
Sponsors Pfizer
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP

Additional content available in CKB BOOST